Stevens-Johnson syndrome, epidermolysis bullosa, staphylococcal scalded skin syndrome, and dermatitis herpetiformis

International Ophthalmology Clinics

Volumn 37, Issue 2, 1997, Pages 77-92

  Hochman, Michael Avery ^a   Mayers, Martin ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; STEROID;

DERMATITIS HERPETIFORMIS; EPIDERMOLYSIS BULLOSA; HUMAN; PRIORITY JOURNAL; RASH; REVIEW; STEROID THERAPY; STEVENS JOHNSON SYNDROME; STOMATITIS; TOXIC EPIDERMAL NECROLYSIS;

DERMATITIS HERPETIFORMIS; EPIDERMOLYSIS BULLOSA; EYE DISEASES; HUMANS; STAPHYLOCOCCAL SCALDED SKIN SYNDROME; STEVENS-JOHNSON SYNDROME;

EID: 0030746452     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004397-199703720-00007     Document Type: Review

References (87)

1. Reed CE, Friedlaender M. Immunologic aspects of diseases of the eye. JAMA 1982;248: 2692-2695
2. Paty A. Ocular involvement in erythema multiforme. Arch Ophthalmol 1950;43: 244-256
3. Strom J. Ocular symptoms in febrile mucocutaneous reactions (ectodermosis erosiva pluriorificialis, Stevens-Johnson's syndrome, mucocutaneous-ocular syndrome, etc.). Acta Ophthalmol (Copenh) 1966;44:411-414
4. Daubeney PE, Scopes JW. Recurrent Stevens-Johnson syndrome. J Soc Med 1991;84: 168-169
5. Hebra F von. On diseases of the skin including the exanthema, translated by CH Fagge. New Sydenham Society, London, 1866, vol. 1, pp. 285-289.
6. Howard GM. The Stevens-Johnson syndrome; ocular prognosis and treatment. Am J Ophthalmol 1963;55:893-900
7. Stevens AM, Johnson FC. A new eruptive fever associated with stomatitis and ophthalmia. Am J Dis Child 1922;24:526-533
8. Lyell A. Toxic epidermal necrolysis: an eruption resembling scalding of the skin. Br J Dermatol 1956;68:355-361
9. James DG. Multi-system ocular syndromes. J R Coll Physicians Lond 1974;9:63-78
10. Chan HL, Stern RS, Arndt KA, et al. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol 1990; 126:43-47
11. Schopf E, Stuhmer A, Rzany B, et al. Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany. Arch Dermatol 1991;127: 839-842
12. Strom BL, Carson JL, Halpern AC, et al. A population-based study of Stevens-Johnson syndrome. Incidence and antecedent drug exposures. Arch Dermatol 1991;127:831-838
13. Belfort R Jr, de Smet M, Whitcup SM, et al. Ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with AIDS. Cornea 1991;10: 536-538
14. Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995;333:1600-1607
15. Kiernan JP, Schanzlin DJ, Leveille AS. Stevens-Johnson syndrome associated with adeno virus conjunctivitis. Am J Ophthalmol 1981;92:543-545
16. Assier H, Bastuji-Garin S, Revuz J, et al. Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes. Arch Dermatol 1995;131:539-543
17. Jones WY. Further studies of Stevens-Johnson disease: report of two cases of purulent conjunctivitis, stomatitis, and cutaneous eruption. Am J Ophthalmol 1950;33:467-470
18. Yetiv JZ, Bianchine JR, Owen JA Jr. Etiologic factors of the Stevens-Johnson syndrome. South Med J 1980;73:599-602
19. Navon SE, Rubin PA. Ectopic conjunctivalisation in Stevens-Johnson syndrome. Br J Ophthalmol 1994;78:727-728
20. Wright P, Collin JRO. The ocular complications of erythema multiforme (Stevens-Johnson syndrome) and their management. Trans Ophthalmol Soc UK 1983;103:338-341
21. Kalhan SB, Ditto SR. Anesthetic management of a child with Stevens-Johnson syndrome. Cleve Clin J Med 1988;55:467-469
22. Arstikaitis MJ. Ocular aftermath of Stevens-Johnson syndrome. Arch Ophthalmol 1973; 90:376-379
23. Calcaterra TC, Strahan RW. Stevens-Johnson syndrome. Oropharyngeal manifestations. Arch Otolaryngol 1971;93:37-41
24. Stitt VJ Jr. Stevens-Johnson svndrome: a review of the literature. J Natl Med Assoc 1988; 80:106-108
25. Kivela T, Tervo K, Ravila E, et al. Pseudomembranous conjunctivitis. Immunochemical features. Acta Ophthalmol (Copenh) 1992;70:534-542
26. Wuepper KD, Watson PA, Kazmierowski JA. Immune complexes in erythema multiforme and the Stevens-Johnson syndrome. J Invest Dermatol 1980;74:368-371
27. Roster CS, Fong LP, Azar D, et al. Episodic conjunctival inflammation after Stevens-Johnson syndrome. Ophthalmology 1988;95:453-462
28. Huff JC, Westen WL, Tonnesen MG. Erythema multiforme: a critical review of characteristics, diagnostic criteria, and causes. J Am Acad Dermatol 1983;8:763-775
29. Patterson R, Miller M, Kaplan M, et al. Effectiveness of early therapy with corticosteroids in Stevens-Johnson syndrome: experience with 41 cases and a hypothesis regarding pathogenesis. Ann Allergy 1994;73:27-34
30. Moudgil A, Porat S, Brunnel P, et al. Treatment of Stevens-Johnson syndrome with pooled human intravenous immune globulin. Clin Pediatr 1995;34:48-51
31. Soter NA, Wuepper KD. Erythema multiforme and Stevens-Johnson syndrome. In: Saunter M, et al., eds. Immunological diseases, ed 4. Boston: Little, Brown, 1988:1257.
32. Mondino BJ, Brown SI, Biglan AW. HLA antigens in Stevens-Johnson syndrome with ocular involvement. Arch Ophthalmol 1982;100:1453-1454.
33. Chan LS, Soong HK, Foster CS, et al. Ocular cicatricial pemphigoid occurring as a sequela of Stevens-Johnson syndrome. JAMA 1991;266:1543-1546
34. Patterson R, Dykewicz MS, Gonzales A, et al. Erythema multiforme and Stevens-Johnson syndrome. Descriptive and therapeutic controversy. Chest 1990;98:331-336
35. Patterson R, Grammar LC, Greenberger PA, et al. StevensJohnson syndrome (SJS): effectiveness of corticosteroids in management and recurrent SJS. Allergy Proc 1992; 13:89-95
36. Prendiville JS, Herbert AA, Greenwald MJ, et al. Management of Stevens-Johnson syndrome and toxic epidermal necrolysis in children. J Pediatr 1989;115:881-887
37. Halebian PH, Corder VJ, Madden MR, et al. Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids. .Ann Surg 1986;204: 503-512
38. Mondino BJ. Cicatricial pemphigoid and erythema multiforme. Ophthalmology 1990; 97:939-952
39. Singer L, Brook L, Romem M, et al. Vitamin A in Stevens-Johnson syndrome. Ann Ophthalmol 1989;21:209-210
40. Gould HL. The dry eve and scleral contact lenses. Am J Ophthalmol 1970;70:37-41
41. Mannor GE, Mathers WD, Wolfley DE, et al. Hard-palate mucosa graft in Stevens-Johnson syndrome. Am J Ophthalmol 1994;118:786-791
42. Kozarsky AM, Knight SH, Waring GO III. Clinical results with a ceramic keratoprosthesis placed through the eyelid. Ophthalmology 1987;94:904-911
43. Olson RJ, Kaufman HE. An abscess associated with a through-the-lid keratoprosthesis one year after intraocular lens insertion. Ophthalmic Surg 1980;11:203-205
44. Auran JD, Hornblass A, Gross ND. Stevens-Johnson syndrome with associated nasolacrimal duct obstruction treated with dacryocystorhinostomy and Crawford silicone tube insertion. Ophthal Plast Reconstr Surg 1990;6:60-63
45. Tabas M, Gibbons S, Bauer EA. The mechanobullous diseases. Dermatol Clin 1987;5: 123-136
46. Lin AN, Murphy F, Brodie SE, et al. Review of ophthalmic findings in 204 patients with epidermolysis bullosa. .Am J Ophthalmol 1994;118:384-390
47. Gans LA. Eye lesions of epidermolysis bullosa. Clinical features, management, and prognosis. Arch Dermatol 1988;124:762-764
48. McDonnell PJ, Spalton DJ. The ocular signs and complications of epidermolysis bullosa. J Royal Soc Med 1988;81:576-578
49. Zierhut M, Thiel HJ, Weidle EG, et al. Ocular involvement in epidermolysis bullosa acquisita. Arch Ophthalmol 1989;107:398-401
50. Granek H, Baden HP. Corneal involvement in epidermolysis bullosa simplex. Arch Ophthalmol 1980;98:469-472
51. Smith LT. Ultrastructural findings in epidermolysis bullosa. Arch Dermatol 1993;129: 1578-1584
52. Eady RA, Dunnill MG. Epidermolysis bullosa: hereditary skin fragility diseases as paradigms in cell biology. Arch Dermatol Res 1994;287:2-9
53. Uitto J, Chrisliano AM. Molecular basis for the dystrophic forms of epidermolysis bullosa: mutations in the type VII collagen gene. Arch Dermatol Res 1994;287:16-22
54. Fine JD. International symposium on epidermolysis bullosa [abstracts]. The University of North Carolina at Chapel Hill, April 25-26, 1994.
55. Bruckner-Tuderman L. Epidermolysis bullosa: pathogenetic pathways from mutations to symptoms. Ann Med 1994;26:165-171
56. Uitto J, Christiano AM. Inherited epidermolysis bullosa. Clinical features, molecular genetics, and pathoetiologic mechanisms. Dermatol Clin 1993;11:549-563
57. Fine JD. Laboratory tests for epidermolysis bullosa. Dermatol Clin 1994;12:123-132
58. McDonnell PJ, Schofield OM, Spalton DJ, et al. Eye involvement in junctional epidermolysis bullosa. Arch Ophthalmol 1989;107:1635-1637
59. Lin AN, Carter DM. Epidermolysis bullosa. Annu Rev Med 1993;44:189-199
60. Caldwell-Brown K, Stern RS, Lin AN, et al. The Epidermolysis Bullosa Study Group. Lack of efficacy of phenytoin in recessive dystrophic epidermolysis bullosa. N Engl J Med 1992;327:163-167
61. Greider JL, Flatt AE. Surgical restoration of the hand in epidermolysis bullosa. Arch Dermatol 1988;124:765-767
62. Schaffer SR. Head and neck manifestations of epidermolysis bullosa. Clin Pediatr 1992; 31:81-88
63. Hardwick N, Parry CM, Sharpe GR. Staphylococcal scalded skin syndrome in an adult. Influence of immune and renal factors. Br J Dermatol 1995;132:468-471
64. Cribier B, Piemont Y, Grosshans E. Staphylococcal scalded skin syndrome in adults. A clinical review illustrated with a new case. J Am Acad Dermatol 1994;30:319-324
65. Goldberg NS, Ahmed T, Robinson B, et al. Staphylococcal scalded skin syndrome mimicking acute graft-vs-host disease in a bone marrow transplant recipient. Arch Dermatol 1989;125:85-87
66. Gemmell CG. Staphylococcal scalded skin syndrome. J Med Microbiol 1995;43:318-327
67. Opal SM, Johnson-Winegar AD, Cross AS. Staphylococcal scalded skin syndrome in two immunocompetent adults caused by exfoliatin B-producing Staphylococcus aureus. J Clin Microbiol 1988;26:1283-1286
68. Richard M, Mathieu-Serra A. Staphylococcal scalded skin syndrome in a homosexual adult. J Am Acad Dermatol 1986;15:385-389
69. O'Keefe R, Dagg JH, MacKie RM. The Staphylococcal scalded skin syndrome in two elderly immunocompromised patients. Br Med J [Clin Res] 1987;295:179-180
70. Ritter von Rittershain G. Die exfoliativa dermatitis jungerer saulinge. Centralz Kinderheilk 1878;2:3-23
71. Melish ME, Glasgow LA. The staphylococcal scalded-skin syndrome. N Engl J Med 1970; 282:1114-1119
72. Herzog JL, Sexton FM. Desquamative rash in an immunotompromised adult. Staphylococcal scalded skin syndrome (SSSS). Arch Dermatol 1990;126:815-816
73. Hoeger PH, Elsner P. Staphylococcal scalded skin syndrome: transmission of exfoliatinproducing Staphylococcus aureus by an asymptomatic carrier. Pediatr Infect Dis J 1988; 7:340-342
74. Dancer SJ, Garratt R, Saldanha J, et al. The epidermolytic toxins are serine proteases. FEBS Lett 1990;268:129-132
75. Murono K, Fujita K, Yoshioka H. Detection of Staphylococcal exfoliative toxin by slide latex agglutination. J Clin Microbiol 1988;26:271-274
76. Itani O, Crump R, Mimouni F, et al. Picture of the month. Ritter's disease (neonatal staphylococcal scalded skin syndrome). AmJ Dis Child 1992;146:425-426
77. Duhring LA. Landmark article, Aug 30, 1884: dermatitis herpetiformis, by Louis A. Duhring. JAMA 1983;250:212-216
78. Fry L, McMinn RMH, Cowan JD, et al. Effect of gluten-free diet on dermatological intestinal and haematological manifestations of dermatitis herpetiformis. Lancet 1967; 1:557-561.
79. Beutner EH, Chorzelski TP, Reunala TL, et al. Immunopathology of dermatitis herpetiformis. Clin Dermatol 1991;9:295-311
80. Smith JB, Tulloch JE, Meyer LJ, et al. The incidence and prevalence of dermatitis herpetiformis in Utah. Arch Dermatol 1992;128:1608-1610
81. Otley C, Hall RP III. Dermatitis herpetiformis. Dermatol Clin 1990;8:759-769
82. Moi H. Incidence and prevalence of dermatitis herpetiformis in a county in central Sweden, with comments on the course of the disease and IgA deposits on diagnostic criterion. Acta Derm Venereol 1984;64:144-150
83. Meyer LJ, Zone JJ. Familial incidence of dermatitis herpetiformis. J Am Acad Dermatol 1987;17:643-647
84. Imber MJ, Kibbi AG, Mihm MC Jr. Dermatitis herpetiformis: histopathologic findings. Clin Dermatol 1991;9:289-293
85. Yunis JJ, Ahmed AR. Immunogenetics of dermatitis herpetiformis. Clin Dermatol 1991; 9:341-346
86. Sachs JA, Leonard J, Awad J, et al. A comparative serological and molecular study of linear IgA disease and dermatitis herpetiformis. Br J Dermatol 1988;118:759-764
87. Gawkrodger DJ, Blackwell JN, Gilmour HM. Dermatitis herpetiformis: diagnosis, diet and demography. Gut 1984;25:151-157